|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 43/42 | |
| A61P 35/00 | |||
| A61K 31/353 | |||
| A61K 31/44 | |||
| A61K 31/496 | |||
| A61K 45/06 |
| (11) | Patento numeris | 3253208 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16747066.5 |
| Europos patento paraiškos padavimo data | 2016-02-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/016008 |
| Data | 2016-02-01 |
| (87) | Numeris | WO 2016/126618 |
| Data | 2016-08-11 |
| (30) | Numeris | Data | Šalis |
| 201562111030 P | 2015-02-02 | US |
| (72) |
GOLD, Daniel P., US
QUINTELA-FANDINO, Miguel, ES
|
| (73) |
MEI Pharma, Inc.,
11455 El Camino Real, Suite 250, San Diego, CA 92130,
US
The Spanish National Cancer Research Centre, Melchor Fernandez Almagro 3, 28029 Madrid, ES |
| (54) | COMBINATION THERAPIES FOR USE IN THE TREATMENT OF BREAST CANCER |
| COMBINATION THERAPIES FOR USE IN THE TREATMENT OF BREAST CANCER |